Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Clinical trial NCT01720407 · COMPLETED
Trial details
- NCT number
- NCT01720407
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2019-10-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.